Benji-13

ATRC BUY 45.06$ SL 40$

Long
NASDAQ:ATRC   AtriCure, Inc
May-08-20 08:47AM AtriCure Announces Results from CONVERGE IDE Clinical Trial Business Wire +7.70%

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.